ACIU•benzinga•
AC Immune Reports Further Interim Results From Phase 2 Trial Of ACI-7104.056 Active Immunotherapy In Early Parkinson's Disease; Says Repeated Immunizations Amplify The Anti-a-syn Antibody Response
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on April 2, 2025 by benzinga